Improvement of Cardiac Vegetations in Antiphospholipid Syndrome with Enoxaparin and Corticosteroids after Rivaroxaban Failure

<div>Follow-up transesophageal echocardiogram at 24 weeks showing a dramatic reduction in the size of the mass between the right and noncoronary cusps.</div>

Case Reports in Hematology

fig2

Figure 2

Figure 2: Improvement of Cardiac Vegetations in Antiphospholipid Syndrome with Enoxaparin and Corticosteroids after Rivaroxaban Failure 